勃林格殷格翰推进其潜在同类首创IL-11抑制剂进入特发性肺纤维化II期临床研究 勃林格殷格翰推进其潜在同类首创IL-11抑制剂进入特发性肺纤维化II期临床研究 勃林格殷格翰推进其潜在同类首创IL-11抑制剂进入特发性肺纤维化II期临床研究
勃林格殷格翰宣布与Jazz制药公司开展临床合作,共同推进乳腺癌HER2靶向疗法 勃林格殷格翰宣布与Jazz制药公司开展临床合作,共同推进乳腺癌HER2靶向疗法 勃林格殷格翰宣布与Jazz制药公司开展临床合作,共同推进乳腺癌HER2靶向疗法
勃林格殷格翰携手京东健康达成全域战略合作,共塑宠物健康数字化新未来 勃林格殷格翰携手京东健康达成全域战略合作,共塑宠物健康数字化新未来 勃林格殷格翰携手京东健康达成全域战略合作,共塑宠物健康数字化新未来
勃林格殷格翰旗下用于治疗HER2突变非小细胞肺癌药物宗艾替尼获FDA局长国家优先审评券 勃林格殷格翰旗下用于治疗HER2突变非小细胞肺癌药物宗艾替尼获FDA局长国家优先审评券 勃林格殷格翰旗下用于治疗HER2突变非小细胞肺癌药物宗艾替尼获FDA局长国家优先审评券
供应商行为准则 供应商行为准则 BI's expectations towards its suppliers on ethical behavior, integrity, professionalism and common business requirements.
我们的预期 我们的预期 We expect adherence to exemplary ethical and professional conduct both within the company and from our business partners.
劳工与人权 劳工与人权 Suppliers shall support and respect the protection of internationally proclaimed human rights.
环境 环境 Suppliers shall operate in an environmentally responsible and efficient manner to minimize adverse impacts on the environment.
健康与安全 健康与安全 Suppliers shall provide a safe and healthy working environment and shall operate environmentally responsible and sustainable.
管理体制 管理体制 Suppliers shall use management systems to support continuous improvement and compliance with the Supplier Code of Conduct.
提出问题或担忧 提出问题或担忧 Supplier must report ethics and compliance concerns that might affect Boehringer Ingelheim.
宗艾替尼在HER2(ERBB2)突变晚期非小细胞肺癌(NSCLC)初治患者中显示出77%的客观缓解率 宗艾替尼在HER2(ERBB2)突变晚期非小细胞肺癌(NSCLC)初治患者中显示出77%的客观缓解率 宗艾替尼在HER2(ERBB2)突变晚期非小细胞肺癌(NSCLC)初治患者中显示出77%的客观缓解率
请扫码关注我们
勃林格殷格翰官方
勃林格殷格翰HR
勃林格殷格翰动保